* Europe says no need to restrict use, in contrast with U.S.
* Says GSK should identify and fix source of contamination
LONDON, March 26 (Reuters) - The European Medicines Agency (EMEA) said on Friday it saw no safety concerns with GlaxoSmithKline’s (GSK.L) (GSK.N) Rotarix vaccine, which has been contaminated with an apparently harmless pig virus.
The agency’s stance contrasts to the United States and Switzerland, where regulators have temporarily stopped doctors using the vaccine which protects children against a diarrhoea-causing virus called rotavirus. [ID:nN22219667] [ID:nLDE62M2G6] EMEA said the unexpected presence of DNA of a non-disease causing viral strain in batches of Rotarix did not present a risk to public health, and there was no need to restrict its use.
However, it said GSK Biologicals, which makes the vaccine, should identify and eradicate the cause of the contamination.
Shares in GlaxoSmithKline were 1.5 percent lower at 1,275 pence at 1359 GMT.
Reporting by Paul Sandle; Editing by Victoria Bryan